The global market for Pulmonary Drug Delivery Devices & Systems was valued at US$ 3264 million in the year 2024 and is projected to reach a revised size of US$ 4250 million by 2031, growing at a CAGR of 3.9% during the forecast period.

Pulmonary Drug Delivery Devices & Systems Market

Pulmonary Drug Delivery Devices/Systems include metered dose inhalers,dry powder inhalers,nebulizers and accessories.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pulmonary Drug Delivery Devices & Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Drug Delivery Devices & Systems.

The Pulmonary Drug Delivery Devices & Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pulmonary Drug Delivery Devices & Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pulmonary Drug Delivery Devices & Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pulmonary Drug Delivery Devices & Systems Market Report

Report Metric	Details
Report Name	Pulmonary Drug Delivery Devices & Systems Market
Accounted market size in year	US$ 3264 million
Forecasted market size in 2031	US$ 4250 million
CAGR	3.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Metered Dose Inhalers Dry Powder Inhalers Nebulizers Accessories
Segment by Application	Hospitals and Clinics Homecare
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Hovione, 3M Health Care, Bespak, BeyonDevices, GlaxoSmithKline, H&T Presspart, PARI Respiratory Equipment, Philips Respironics, SHL
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pulmonary Drug Delivery Devices & Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pulmonary Drug Delivery Devices & Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pulmonary Drug Delivery Devices & Systems Market growing?

Ans: The Pulmonary Drug Delivery Devices & Systems Market witnessing a CAGR of 3.9% during the forecast period 2025-2031.

What is the Pulmonary Drug Delivery Devices & Systems Market size in 2031?

Ans: The Pulmonary Drug Delivery Devices & Systems Market size in 2031 will be US$ 4250 million.

Who are the main players in the Pulmonary Drug Delivery Devices & Systems Market report?

Ans: The main players in the Pulmonary Drug Delivery Devices & Systems Market are Hovione, 3M Health Care, Bespak, BeyonDevices, GlaxoSmithKline, H&T Presspart, PARI Respiratory Equipment, Philips Respironics, SHL

What are the Application segmentation covered in the Pulmonary Drug Delivery Devices & Systems Market report?

Ans: The Applications covered in the Pulmonary Drug Delivery Devices & Systems Market report are Hospitals and Clinics, Homecare

What are the Type segmentation covered in the Pulmonary Drug Delivery Devices & Systems Market report?

Ans: The Types covered in the Pulmonary Drug Delivery Devices & Systems Market report are Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Accessories

1 Pulmonary Drug Delivery Devices & Systems Market Overview

1.1 Product Definition

1.2 Pulmonary Drug Delivery Devices & Systems by Type

1.2.1 Global Pulmonary Drug Delivery Devices & Systems Market Value Comparison by Type (2024 VS 2031)

1.2.2 Metered Dose Inhalers

1.2.3 Dry Powder Inhalers

1.2.4 Nebulizers

1.2.5 Accessories

1.3 Pulmonary Drug Delivery Devices & Systems by Application

1.3.1 Global Pulmonary Drug Delivery Devices & Systems Market Value by Application (2024 VS 2031)

1.3.2 Hospitals and Clinics

1.3.3 Homecare

1.4 Global Pulmonary Drug Delivery Devices & Systems Market Size Estimates and Forecasts

1.4.1 Global Pulmonary Drug Delivery Devices & Systems Revenue 2020-2031

1.4.2 Global Pulmonary Drug Delivery Devices & Systems Sales 2020-2031

1.4.3 Global Pulmonary Drug Delivery Devices & Systems Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Pulmonary Drug Delivery Devices & Systems Market Competition by Manufacturers

2.1 Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pulmonary Drug Delivery Devices & Systems Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pulmonary Drug Delivery Devices & Systems, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pulmonary Drug Delivery Devices & Systems, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pulmonary Drug Delivery Devices & Systems, Product Type & Application

2.7 Global Key Manufacturers of Pulmonary Drug Delivery Devices & Systems, Date of Enter into This Industry

2.8 Global Pulmonary Drug Delivery Devices & Systems Market Competitive Situation and Trends

2.8.1 Global Pulmonary Drug Delivery Devices & Systems Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pulmonary Drug Delivery Devices & Systems Players Market Share by Revenue

2.8.3 Global Pulmonary Drug Delivery Devices & Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pulmonary Drug Delivery Devices & Systems Market Scenario by Region

3.1 Global Pulmonary Drug Delivery Devices & Systems Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pulmonary Drug Delivery Devices & Systems Sales by Region: 2020-2031

3.2.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Region: 2020-2025

3.2.2 Global Pulmonary Drug Delivery Devices & Systems Sales by Region: 2026-2031

3.3 Global Pulmonary Drug Delivery Devices & Systems Revenue by Region: 2020-2031

3.3.1 Global Pulmonary Drug Delivery Devices & Systems Revenue by Region: 2020-2025

3.3.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Region: 2026-2031

3.4 North America Pulmonary Drug Delivery Devices & Systems Market Facts & Figures by Country

3.4.1 North America Pulmonary Drug Delivery Devices & Systems Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pulmonary Drug Delivery Devices & Systems Sales by Country (2020-2031)

3.4.3 North America Pulmonary Drug Delivery Devices & Systems Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pulmonary Drug Delivery Devices & Systems Market Facts & Figures by Country

3.5.1 Europe Pulmonary Drug Delivery Devices & Systems Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pulmonary Drug Delivery Devices & Systems Sales by Country (2020-2031)

3.5.3 Europe Pulmonary Drug Delivery Devices & Systems Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pulmonary Drug Delivery Devices & Systems Market Facts & Figures by Region

3.6.1 Asia Pacific Pulmonary Drug Delivery Devices & Systems Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pulmonary Drug Delivery Devices & Systems Sales by Region (2020-2031)

3.6.3 Asia Pacific Pulmonary Drug Delivery Devices & Systems Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Pulmonary Drug Delivery Devices & Systems Market Facts & Figures by Country

3.7.1 Latin America Pulmonary Drug Delivery Devices & Systems Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pulmonary Drug Delivery Devices & Systems Sales by Country (2020-2031)

3.7.3 Latin America Pulmonary Drug Delivery Devices & Systems Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pulmonary Drug Delivery Devices & Systems Market Facts & Figures by Country

3.8.1 Middle East and Africa Pulmonary Drug Delivery Devices & Systems Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pulmonary Drug Delivery Devices & Systems Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pulmonary Drug Delivery Devices & Systems Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Type (2020-2031)

4.1.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Type (2020-2025)

4.1.2 Global Pulmonary Drug Delivery Devices & Systems Sales by Type (2026-2031)

4.1.3 Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Type (2020-2031)

4.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Type (2020-2031)

4.2.1 Global Pulmonary Drug Delivery Devices & Systems Revenue by Type (2020-2025)

4.2.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Type (2026-2031)

4.2.3 Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Type (2020-2031)

4.3 Global Pulmonary Drug Delivery Devices & Systems Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Application (2020-2031)

5.1.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Application (2020-2025)

5.1.2 Global Pulmonary Drug Delivery Devices & Systems Sales by Application (2026-2031)

5.1.3 Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Application (2020-2031)

5.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Application (2020-2031)

5.2.1 Global Pulmonary Drug Delivery Devices & Systems Revenue by Application (2020-2025)

5.2.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Application (2026-2031)

5.2.3 Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Application (2020-2031)

5.3 Global Pulmonary Drug Delivery Devices & Systems Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Hovione

6.1.1 Hovione Company Information

6.1.2 Hovione Description and Business Overview

6.1.3 Hovione Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Hovione Pulmonary Drug Delivery Devices & Systems Product Portfolio

6.1.5 Hovione Recent Developments/Updates

6.2 3M Health Care

6.2.1 3M Health Care Company Information

6.2.2 3M Health Care Description and Business Overview

6.2.3 3M Health Care Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2020-2025)

6.2.4 3M Health Care Pulmonary Drug Delivery Devices & Systems Product Portfolio

6.2.5 3M Health Care Recent Developments/Updates

6.3 Bespak

6.3.1 Bespak Company Information

6.3.2 Bespak Description and Business Overview

6.3.3 Bespak Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Bespak Pulmonary Drug Delivery Devices & Systems Product Portfolio

6.3.5 Bespak Recent Developments/Updates

6.4 BeyonDevices

6.4.1 BeyonDevices Company Information

6.4.2 BeyonDevices Description and Business Overview

6.4.3 BeyonDevices Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2020-2025)

6.4.4 BeyonDevices Pulmonary Drug Delivery Devices & Systems Product Portfolio

6.4.5 BeyonDevices Recent Developments/Updates

6.5 GlaxoSmithKline

6.5.1 GlaxoSmithKline Company Information

6.5.2 GlaxoSmithKline Description and Business Overview

6.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2020-2025)

6.5.4 GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Product Portfolio

6.5.5 GlaxoSmithKline Recent Developments/Updates

6.6 H&T Presspart

6.6.1 H&T Presspart Company Information

6.6.2 H&T Presspart Description and Business Overview

6.6.3 H&T Presspart Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2020-2025)

6.6.4 H&T Presspart Pulmonary Drug Delivery Devices & Systems Product Portfolio

6.6.5 H&T Presspart Recent Developments/Updates

6.7 PARI Respiratory Equipment

6.7.1 PARI Respiratory Equipment Company Information

6.7.2 PARI Respiratory Equipment Description and Business Overview

6.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2020-2025)

6.7.4 PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Product Portfolio

6.7.5 PARI Respiratory Equipment Recent Developments/Updates

6.8 Philips Respironics

6.8.1 Philips Respironics Company Information

6.8.2 Philips Respironics Description and Business Overview

6.8.3 Philips Respironics Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Philips Respironics Pulmonary Drug Delivery Devices & Systems Product Portfolio

6.8.5 Philips Respironics Recent Developments/Updates

6.9 SHL

6.9.1 SHL Company Information

6.9.2 SHL Description and Business Overview

6.9.3 SHL Pulmonary Drug Delivery Devices & Systems Sales, Revenue and Gross Margin (2020-2025)

6.9.4 SHL Pulmonary Drug Delivery Devices & Systems Product Portfolio

6.9.5 SHL Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pulmonary Drug Delivery Devices & Systems Industry Chain Analysis

7.2 Pulmonary Drug Delivery Devices & Systems Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pulmonary Drug Delivery Devices & Systems Production Mode & Process Analysis

7.4 Pulmonary Drug Delivery Devices & Systems Sales and Marketing

7.4.1 Pulmonary Drug Delivery Devices & Systems Sales Channels

7.4.2 Pulmonary Drug Delivery Devices & Systems Distributors

7.5 Pulmonary Drug Delivery Devices & Systems Customer Analysis

8 Pulmonary Drug Delivery Devices & Systems Market Dynamics

8.1 Pulmonary Drug Delivery Devices & Systems Industry Trends

8.2 Pulmonary Drug Delivery Devices & Systems Market Drivers

8.3 Pulmonary Drug Delivery Devices & Systems Market Challenges

8.4 Pulmonary Drug Delivery Devices & Systems Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

PARI Respiratory Equipment

Philips Respironics

SHL

List of Tables

Table 1. Global Pulmonary Drug Delivery Devices & Systems Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pulmonary Drug Delivery Devices & Systems Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Pulmonary Drug Delivery Devices & Systems Market Competitive Situation by Manufacturers in 2024

Table 4. Global Pulmonary Drug Delivery Devices & Systems Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Pulmonary Drug Delivery Devices & Systems Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Pulmonary Drug Delivery Devices & Systems Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Pulmonary Drug Delivery Devices & Systems Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Pulmonary Drug Delivery Devices & Systems, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pulmonary Drug Delivery Devices & Systems, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pulmonary Drug Delivery Devices & Systems, Product Type & Application

Table 12. Global Key Manufacturers of Pulmonary Drug Delivery Devices & Systems, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pulmonary Drug Delivery Devices & Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Drug Delivery Devices & Systems as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pulmonary Drug Delivery Devices & Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Pulmonary Drug Delivery Devices & Systems Sales by Region (2020-2025) & (K Units)

Table 18. Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Region (2020-2025)

Table 19. Global Pulmonary Drug Delivery Devices & Systems Sales by Region (2026-2031) & (K Units)

Table 20. Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Region (2026-2031)

Table 21. Global Pulmonary Drug Delivery Devices & Systems Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Region (2020-2025)

Table 23. Global Pulmonary Drug Delivery Devices & Systems Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Region (2026-2031)

Table 25. North America Pulmonary Drug Delivery Devices & Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Pulmonary Drug Delivery Devices & Systems Sales by Country (2020-2025) & (K Units)

Table 27. North America Pulmonary Drug Delivery Devices & Systems Sales by Country (2026-2031) & (K Units)

Table 28. North America Pulmonary Drug Delivery Devices & Systems Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Pulmonary Drug Delivery Devices & Systems Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Pulmonary Drug Delivery Devices & Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Pulmonary Drug Delivery Devices & Systems Sales by Country (2020-2025) & (K Units)

Table 32. Europe Pulmonary Drug Delivery Devices & Systems Sales by Country (2026-2031) & (K Units)

Table 33. Europe Pulmonary Drug Delivery Devices & Systems Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Pulmonary Drug Delivery Devices & Systems Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Pulmonary Drug Delivery Devices & Systems Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Pulmonary Drug Delivery Devices & Systems Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Pulmonary Drug Delivery Devices & Systems Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Pulmonary Drug Delivery Devices & Systems Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Pulmonary Drug Delivery Devices & Systems Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Pulmonary Drug Delivery Devices & Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Pulmonary Drug Delivery Devices & Systems Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Pulmonary Drug Delivery Devices & Systems Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Pulmonary Drug Delivery Devices & Systems Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pulmonary Drug Delivery Devices & Systems Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Pulmonary Drug Delivery Devices & Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Pulmonary Drug Delivery Devices & Systems Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Pulmonary Drug Delivery Devices & Systems Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Pulmonary Drug Delivery Devices & Systems Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Pulmonary Drug Delivery Devices & Systems Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Pulmonary Drug Delivery Devices & Systems Sales (K Units) by Type (2020-2025)

Table 51. Global Pulmonary Drug Delivery Devices & Systems Sales (K Units) by Type (2026-2031)

Table 52. Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Type (2020-2025)

Table 53. Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Type (2026-2031)

Table 54. Global Pulmonary Drug Delivery Devices & Systems Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Pulmonary Drug Delivery Devices & Systems Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Type (2020-2025)

Table 57. Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Type (2026-2031)

Table 58. Global Pulmonary Drug Delivery Devices & Systems Price (USD/Unit) by Type (2020-2025)

Table 59. Global Pulmonary Drug Delivery Devices & Systems Price (USD/Unit) by Type (2026-2031)

Table 60. Global Pulmonary Drug Delivery Devices & Systems Sales (K Units) by Application (2020-2025)

Table 61. Global Pulmonary Drug Delivery Devices & Systems Sales (K Units) by Application (2026-2031)

Table 62. Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Application (2020-2025)

Table 63. Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Application (2026-2031)

Table 64. Global Pulmonary Drug Delivery Devices & Systems Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Pulmonary Drug Delivery Devices & Systems Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Application (2020-2025)

Table 67. Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Application (2026-2031)

Table 68. Global Pulmonary Drug Delivery Devices & Systems Price (USD/Unit) by Application (2020-2025)

Table 69. Global Pulmonary Drug Delivery Devices & Systems Price (USD/Unit) by Application (2026-2031)

Table 70. Hovione Company Information

Table 71. Hovione Description and Business Overview

Table 72. Hovione Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Hovione Pulmonary Drug Delivery Devices & Systems Product

Table 74. Hovione Recent Developments/Updates

Table 75. 3M Health Care Company Information

Table 76. 3M Health Care Description and Business Overview

Table 77. 3M Health Care Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. 3M Health Care Pulmonary Drug Delivery Devices & Systems Product

Table 79. 3M Health Care Recent Developments/Updates

Table 80. Bespak Company Information

Table 81. Bespak Description and Business Overview

Table 82. Bespak Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Bespak Pulmonary Drug Delivery Devices & Systems Product

Table 84. Bespak Recent Developments/Updates

Table 85. BeyonDevices Company Information

Table 86. BeyonDevices Description and Business Overview

Table 87. BeyonDevices Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. BeyonDevices Pulmonary Drug Delivery Devices & Systems Product

Table 89. BeyonDevices Recent Developments/Updates

Table 90. GlaxoSmithKline Company Information

Table 91. GlaxoSmithKline Description and Business Overview

Table 92. GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Product

Table 94. GlaxoSmithKline Recent Developments/Updates

Table 95. H&T Presspart Company Information

Table 96. H&T Presspart Description and Business Overview

Table 97. H&T Presspart Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. H&T Presspart Pulmonary Drug Delivery Devices & Systems Product

Table 99. H&T Presspart Recent Developments/Updates

Table 100. PARI Respiratory Equipment Company Information

Table 101. PARI Respiratory Equipment Description and Business Overview

Table 102. PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Product

Table 104. PARI Respiratory Equipment Recent Developments/Updates

Table 105. Philips Respironics Company Information

Table 106. Philips Respironics Description and Business Overview

Table 107. Philips Respironics Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Philips Respironics Pulmonary Drug Delivery Devices & Systems Product

Table 109. Philips Respironics Recent Developments/Updates

Table 110. SHL Company Information

Table 111. SHL Description and Business Overview

Table 112. SHL Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. SHL Pulmonary Drug Delivery Devices & Systems Product

Table 114. SHL Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Pulmonary Drug Delivery Devices & Systems Distributors List

Table 118. Pulmonary Drug Delivery Devices & Systems Customers List

Table 119. Pulmonary Drug Delivery Devices & Systems Market Trends

Table 120. Pulmonary Drug Delivery Devices & Systems Market Drivers

Table 121. Pulmonary Drug Delivery Devices & Systems Market Challenges

Table 122. Pulmonary Drug Delivery Devices & Systems Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pulmonary Drug Delivery Devices & Systems

Figure 2. Global Pulmonary Drug Delivery Devices & Systems Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pulmonary Drug Delivery Devices & Systems Market Share by Type: 2024 & 2031

Figure 4. Metered Dose Inhalers Product Picture

Figure 5. Dry Powder Inhalers Product Picture

Figure 6. Nebulizers Product Picture

Figure 7. Accessories Product Picture

Figure 8. Global Pulmonary Drug Delivery Devices & Systems Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Pulmonary Drug Delivery Devices & Systems Market Share by Application: 2024 & 2031

Figure 10. Hospitals and Clinics

Figure 11. Homecare

Figure 12. Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Pulmonary Drug Delivery Devices & Systems Market Size (2020-2031) & (US$ Million)

Figure 14. Global Pulmonary Drug Delivery Devices & Systems Sales (2020-2031) & (K Units)

Figure 15. Global Pulmonary Drug Delivery Devices & Systems Average Price (USD/Unit) & (2020-2031)

Figure 16. Pulmonary Drug Delivery Devices & Systems Report Years Considered

Figure 17. Pulmonary Drug Delivery Devices & Systems Sales Share by Manufacturers in 2024

Figure 18. Global Pulmonary Drug Delivery Devices & Systems Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Pulmonary Drug Delivery Devices & Systems Players: Market Share by Revenue in Pulmonary Drug Delivery Devices & Systems in 2024

Figure 20. Pulmonary Drug Delivery Devices & Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Pulmonary Drug Delivery Devices & Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Pulmonary Drug Delivery Devices & Systems Sales Market Share by Country (2020-2031)

Figure 23. North America Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Pulmonary Drug Delivery Devices & Systems Sales Market Share by Country (2020-2031)

Figure 27. Europe Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Country (2020-2031)

Figure 28. Germany Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Pulmonary Drug Delivery Devices & Systems Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Region (2020-2031)

Figure 35. China Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Pulmonary Drug Delivery Devices & Systems Sales Market Share by Country (2020-2031)

Figure 45. Latin America Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Pulmonary Drug Delivery Devices & Systems Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Pulmonary Drug Delivery Devices & Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Pulmonary Drug Delivery Devices & Systems by Type (2020-2031)

Figure 55. Global Revenue Market Share of Pulmonary Drug Delivery Devices & Systems by Type (2020-2031)

Figure 56. Global Pulmonary Drug Delivery Devices & Systems Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Pulmonary Drug Delivery Devices & Systems by Application (2020-2031)

Figure 58. Global Revenue Market Share of Pulmonary Drug Delivery Devices & Systems by Application (2020-2031)

Figure 59. Global Pulmonary Drug Delivery Devices & Systems Price (USD/Unit) by Application (2020-2031)

Figure 60. Pulmonary Drug Delivery Devices & Systems Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions